The Effect of Standardizing Procedures for SC Injections of LMWH on Patients With CVD
Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.
| Condition(s) | CVD - Cardiovascular Disease, Bruise, Pain |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings. |
| Who can participate | Inclusion Criteria: * patients who are in cardiac care units suffering from cardiovascular diseases prescribed with LMWH injections two times per day * Chinese Exclusion Criteria: * cognitively impaired * unconscious * refuse to participate |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | The Hong Kong Polytechnic University |
| Locations | Hong Kong, Hong Kong |
| Start date | 2025-06-24 |
| NCT ID | NCT06776159 |
| Official listing | https://clinicaltrials.gov/study/NCT06776159 |